Session Details

Hot Line: Late Breaking Clinical Trials 1
27 Aug 11:00 - 12:30 Miscellaneous Hot Line Barcelona - Main Auditorium
Chairpersons: Jeroen BAX (Leiden, Netherlands), Barbara CASADEI (Oxford, United Kingdom)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
11:00 Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 studyMichiel RIENSTRA (Groningen, Netherlands)
11:10 Discussant review: Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study. Josep BRUGADA TERRADELLAS (Barcelona, Spain)
11:15 Panel discussion. 
11:18 Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trialNassir MARROUCHE (Salt Lake City, United States of America)
11:28 Discussant review: Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trialCarina BLOMSTROM-LUNDQVIST (Uppsala, Sweden)
11:33 Panel discussion. 
11:36 CANTOS - The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study Paul M RIDKER (Boston, United States of America)
11:46 Discussant review: CANTOS - The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study  
11:51 Panel discussion. 
11:54 Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results John William EIKELBOOM (Hamilton, Canada)
12:04 Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary ResultsEugene BRAUNWALD (Boston, United States of America)
12:09 Panel discussion. 
12:12 Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Results in Patients with Coronary Artery Disease and in patients with Peripheral Artery Disease.Sonia ANAND (Hamilton, Canada)
12:22 Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Results in Patients with Coronary Artery Disease and in patients with Peripheral Artery Disease.Lars WALLENTIN (Uppsala, Sweden)
12:27 Panel discussion. 

Who we are

What we do

How we work

More ESC